[使用间羟异丙肾上腺素（舒喘灵）作为子宫收缩抑制剂的临床经验] - Suppr | 超能文献

[Clinical experience in the use of orciprenaline (Alupent) as an inhibitor of uterine contractility].

作者信息

Chargoy Vera J, Hoyo Garza R, Tapia Ruiz J A

出版信息

Ginecol Obstet Mex. 1971 Jan;29(171):81-9.

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

[Clinical experience in the use of orciprenaline (Alupent) as an inhibitor of uterine contractility].[使用间羟异丙肾上腺素（舒喘灵）作为子宫收缩抑制剂的临床经验]

Ginecol Obstet Mex. 1971 Jan;29(171):81-9.

2

Action of orciprenaline on uterine contractility during labor, maternal cardiovascular system, fetal heart rate, and acid-base balance.间羟异丙肾上腺素在分娩时对子宫收缩力、母体心血管系统、胎儿心率及酸碱平衡的作用。

Am J Obstet Gynecol. 1971 Apr 1;109(7):1073-9. doi: 10.1016/0002-9378(71)90292-4.

3

[Action of orciprenaline on uterine contractility].[间羟异丙肾上腺素对子宫收缩性的作用]

Ginecol Obstet Mex. 1971 Mar;29(173):301-18.

4

[Inhibition of the contractility of the uterus in threatened premature labor using orciprenaline (Alupent). Preliminary report].[使用间羟异丙肾上腺素（喘咳宁）抑制先兆早产子宫的收缩力。初步报告]

Rev Colomb Obstet Ginecol. 1970 Mar-Apr;21(2):111-7.

5

[Effect of Tranquo-Alupent in asthmatic syndrome].[喘静-异丙肾上腺素在哮喘综合征中的作用]

Ther Ggw. 1969 Sep;108(9):1298 passim.

6

[Comparative study of the bronchospasmolytic effect of alupent and aleudrine by spirometric examination of pulmonary ventilation].[通过肺通气量测定法对异丙喘宁和肾上腺素的支气管解痉作用进行比较研究]

Lijec Vjesn. 1970;92(2):217-22.

7

[Ceglunat intoxication in childhood and treatment with Alupent].[儿童西格鲁那中毒及用异丙肾上腺素治疗]

Dtsch Gesundheitsw. 1971 Feb 18;26(8):364-7.

8

[On a case of cardiac arrest resolved by intracardiac injection of Alupent. (Case report)].[关于一例通过心内注射间羟异丙肾上腺素成功解决心脏骤停的病例。（病例报告）]

Minerva Cardioangiol. 1966 Aug;14(8):493-8.

9

[Clinical experimentation using injectable metaproteronol].[使用注射用间羟异丙肾上腺素的临床试验]

Hospital (Rio J). 1967 Sep;72(3):913-8.

10

The bronchodilator effects of orciprenaline and salbutamol. A double-blind study.间羟异丙肾上腺素和沙丁胺醇的支气管扩张作用。一项双盲研究。

Postgrad Med J. 1971 Mar;47:Suppl:83-6.